| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.26B | 47.73B | 45.42B | 42.79B | 49.60B | 35.41B |
| Gross Profit | 9.84B | 10.96B | 9.63B | 8.26B | 9.41B | 8.05B |
| EBITDA | 6.89B | 7.79B | 6.53B | 5.50B | 6.67B | 5.18B |
| Net Income | 3.44B | 4.36B | 3.13B | 2.38B | 3.23B | 2.54B |
Balance Sheet | ||||||
| Total Assets | 45.72B | 49.97B | 46.85B | 45.03B | 48.16B | 42.35B |
| Cash, Cash Equivalents and Short-Term Investments | 4.64B | 4.82B | 5.05B | 3.40B | 4.94B | 3.54B |
| Total Debt | 8.20B | 7.51B | 8.47B | 9.02B | 12.27B | 11.26B |
| Total Liabilities | 17.90B | 18.13B | 18.97B | 20.06B | 24.91B | 22.05B |
| Stockholders Equity | 27.82B | 31.84B | 27.88B | 24.97B | 23.13B | 20.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.78B | 3.17B | 3.99B | 1.12B | -434.00M |
| Operating Cash Flow | 0.00 | 6.15B | 5.04B | 4.97B | 2.04B | 2.00B |
| Investing Cash Flow | 0.00 | -4.49B | -1.83B | -1.89B | -961.00M | -2.32B |
| Financing Cash Flow | 0.00 | -1.96B | -1.64B | -4.74B | 245.00M | 308.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥116.67B | 8.38 | ― | 3.72% | 4.49% | 27.96% | |
76 Outperform | ¥121.70B | 17.95 | ― | 1.30% | 26.33% | 11.15% | |
75 Outperform | ¥74.10B | 14.74 | ― | 2.22% | 5.08% | 39.85% | |
75 Outperform | ¥79.25B | 26.37 | ― | 1.12% | 5.01% | 1.83% | |
74 Outperform | ¥91.94B | 11.05 | ― | 3.02% | 0.51% | 3.23% | |
73 Outperform | ¥76.30B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |